1. Home
  2. BULL vs RYTM Comparison

BULL vs RYTM Comparison

Compare BULL & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BULL
  • RYTM
  • Stock Information
  • Founded
  • BULL 2016
  • RYTM 2008
  • Country
  • BULL United States
  • RYTM United States
  • Employees
  • BULL N/A
  • RYTM N/A
  • Industry
  • BULL
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • BULL
  • RYTM Health Care
  • Exchange
  • BULL NYSE
  • RYTM Nasdaq
  • Market Cap
  • BULL 4.8B
  • RYTM 4.3B
  • IPO Year
  • BULL N/A
  • RYTM 2017
  • Fundamental
  • Price
  • BULL $14.27
  • RYTM $65.77
  • Analyst Decision
  • BULL
  • RYTM Strong Buy
  • Analyst Count
  • BULL 0
  • RYTM 12
  • Target Price
  • BULL N/A
  • RYTM $77.50
  • AVG Volume (30 Days)
  • BULL 10.1M
  • RYTM 631.5K
  • Earning Date
  • BULL 08-23-2025
  • RYTM 08-05-2025
  • Dividend Yield
  • BULL N/A
  • RYTM N/A
  • EPS Growth
  • BULL N/A
  • RYTM N/A
  • EPS
  • BULL 4.12
  • RYTM N/A
  • Revenue
  • BULL $417,404,401.00
  • RYTM $136,863,000.00
  • Revenue This Year
  • BULL N/A
  • RYTM $37.56
  • Revenue Next Year
  • BULL N/A
  • RYTM $74.99
  • P/E Ratio
  • BULL $3.49
  • RYTM N/A
  • Revenue Growth
  • BULL 11.41
  • RYTM 48.88
  • 52 Week Low
  • BULL $9.54
  • RYTM $40.46
  • 52 Week High
  • BULL $79.56
  • RYTM $69.89
  • Technical
  • Relative Strength Index (RSI)
  • BULL N/A
  • RYTM 57.57
  • Support Level
  • BULL N/A
  • RYTM $60.80
  • Resistance Level
  • BULL N/A
  • RYTM $67.75
  • Average True Range (ATR)
  • BULL 0.00
  • RYTM 2.08
  • MACD
  • BULL 0.00
  • RYTM 0.26
  • Stochastic Oscillator
  • BULL 0.00
  • RYTM 71.91

About BULL WEBULL CORPORATION

Webull Corp is a digital investment platform built upon a next-generation global infrastructure. It strives to be the platform of choice for a new generation of investors by creating an efficient, low-cost, and easy-to-use global investment platform. The company distinguishes itself from other investment service providers by offering a mobile-first user experience, a broad range of investment products, and extensive functionality constructed to help its customers build wealth over time. The company arms each customer with the tools it needs to develop into what it refers to as an informed investor - one who understands the market and has the confidence to succeed as an investor. The Webull platform originally provided users with free access to market data and analytical tools.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: